Eaton Vance Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $170M | Buy |
|
|||||
|
2022
Q2 | $160M | Buy |
|
|||||
|
2022
Q1 | $182M | Buy |
|
|||||
|
2021
Q4 | $160M | Sell |
|
|||||
|
2021
Q3 | $171M | Sell |
|
|||||
|
2021
Q2 | $176M | Sell |
|
|||||
|
2021
Q1 | $175M | Sell |
|
|||||
|
2020
Q4 | $198M | Sell |
|
|||||
|
2020
Q3 | $256M | Buy |
|
|||||
|
2020
Q2 | $220M | Buy |
|
|||||
|
2020
Q1 | $88.1M | Sell |
|
|||||
|
2019
Q4 | $152M | Buy |
|
|||||
|
2019
Q3 | $126M | Buy |
|
|||||
|
2019
Q2 | $113M | Buy |
|
|||||
|
2019
Q1 | $96.9M | Sell |
|
|||||
|
2018
Q4 | $134M | Sell |
|
|||||
|
2018
Q3 | $205M | Sell |
|
|||||
|
2018
Q2 | $187M | Sell |
|
|||||
|
2018
Q1 | $359M | Buy |
|
|||||
|
2017
Q4 | $114M | Buy |
|
|||||
|
2017
Q3 | $98.5M | Buy |
|
|||||
|
2017
Q2 | $86.9M | Buy |
|
|||||
|
2017
Q1 | $44.7M | Buy |
|
|||||
|
2016
Q4 | $578K | Sell |
|
|||||
|
2016
Q3 | $41M | Sell |
|
|||||
|
2016
Q2 | $91.3M | Buy |
|
|||||
|
2016
Q1 | $514K | Sell |
|
|||||
|
2015
Q4 | $519K | Buy |
|
|||||
|
2015
Q3 | $448K | Hold |
|
|||||
|
2015
Q2 | $484K | Sell |
|
|||||
|
2015
Q1 | $486K | Sell |
|
|||||
|
2014
Q4 | $364K | Sell |
|
|||||
|
2014
Q3 | $326K | Sell |
|
|||||
|
2014
Q2 | $356K | Buy |
|
|||||
|
2014
Q1 | $370K | Buy |
|
|||||
|
2013
Q4 | $329K | Buy |
|
|||||
|
2013
Q3 | $321K | Buy |
|
|||||
|
2013
Q2 | $254K | Buy |
|